Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy (CONSIGN)

Expanded access is no longer available for this treatment.

Sponsor:

Information provided by (Responsible Party):

Bayer

ClinicalTrials.gov Identifier:

NCT01538680

First received: February 21, 2012

Last updated: June 29, 2016

Last verified: June 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	Expanded access is no longer available for this treatment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given